Welcome

Sign out Have a question? We're here to help

Sign out

Cassava Sciences Inc (SAVA)

$4.64 0.18 (3.73%)

16:00 EDT SAVA Stock Quote Delayed 20 Minutes

Volume:

Previous Close $4.64

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 436,700

Day's Range 4.53 - 4.95

52-Week Range 1.00 - 10.95

Dividend & Yield N/A (N/A)

SAVA Stock Predictions, Articles, and Cassava Sciences Inc News

From the Web

Healthcare - Top 5 Gainers / Losers

From Seeking Alpha Apr 2, 2020

Gainers: Cellect Biotechnology (NASDAQ:APOP) +165%. RAPT Therapeutics (NASDAQ:RAPT) +22%. Cassava Sciences (NASDAQ:SAVA) +18%. La Jolla Pharmaceutical (NASDAQ:LJPC) +17%. Neptune Wellness Solutions (N

Cassava Sciences files for $200M mixed shelf

From Seeking Alpha Mar 28, 2020

Cassava Sciences (NASDAQ:SAVA) has filed a prospectus for a $200M mixed shelf offering.

Cassava launches extension study of lead drug in Alzheimer's

From Seeking Alpha Mar 25, 2020

On the heels of positive interim results from a Phase 2a clinical trial, Cassava Sciences (NASDAQ:SAVA) initiates an open-label extension study evaluating lead candidate PTI-125 in ~100 patients with

Read This Before Selling Cassava Sciences, Inc. (NASDAQ:SAVA) Shares

From Simply Wall St Mar 23, 2020

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sava/cassava-sciences/news/read-this-before-selling-cassava-sciences-inc-nasdaqsava-shares/">Read More...</a></div>

Cassava Sciences +11% premarket on clinical updates

From Seeking Alpha Mar 19, 2020

Cassava Sciences (NASDAQ:SAVA) announces clinical updates and business progress across its product candidates under development. In 2019, a Phase 2a clinical study showed that open-label treatment wi

144 Biggest Movers From Friday

From Benzinga Mar 16, 2020

Gainers Contura Energy, Inc. (NYSE: CTRA) shares surged 64.7% to close at $4.89 on Friday. Contura is expected to release Q4 results on March 18. Exterran Corporation (NYSE: EXTN...

Navellier Ratings

Total Grade

Strong Buy

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Breaking news

Cassava Sciences Inc (SAVA)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Breaking news

Cassava Sciences Inc (SAVA)

SAVA Stock Predictions, Articles, and Cassava Sciences Inc News

Healthcare - Top 5 Gainers / Losers

Cassava Sciences files for $200M mixed shelf

Cassava launches extension study of lead drug in Alzheimer's

Read This Before Selling Cassava Sciences, Inc. (NASDAQ:SAVA) Shares

Cassava Sciences +11% premarket on clinical updates

144 Biggest Movers From Friday

Navellier Ratings

Total Grade

Subscriber Sign in